Steven A. Ledger - 03 Feb 2026 Form 4 Insider Report for Serina Therapeutics, Inc. (SER)

Role: Chief Executive Officer, Director
Signature: Steven A. Ledger
Issuer symbol: SER
Transactions as of: 03 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 17 Feb 2026, 08:20:35 UTC
Previous filing: 01 Apr 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
LEDGER STEVEN A	Chief Executive Officer, Director	601 GENOME WAY, SUITE 2001, HUNTSVILLE	Steven A. Ledger	17 Feb 2026	0001090206

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SER	Stock Option (right to buy)	Award	$0	+230,100		$0.000000	230,100	03 Feb 2026	Common Stock	230,100	$2.76	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Unless otherwise terminated as provided in the optionee's option agreement, 12/48ths of the shares subject to the option shall vest twelve months after the Vesting Commencement Date, and 1/48th of the shares subject to the option shall vest on the same calendar day of each subsequent month thereafter until the shares subject to the option are fully vested.